Physician profile
Manabu Takebe
NPI 1366853368
$18,192.95
in general payments reported to CMS, 2019-2025
16 companies · $3,169 in 2025
The $3,169 reported for 2025 was more than what 75% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,510 · 2020: $341 · 2021: $1,488 · 2022: $1,240 · 2023: $2,371 · 2024: $3,074 · 2025: $3,169.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,004 · Travel and Lodging: $1,609.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,004.37 |
| Travel and Lodging | $1,608.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $3,310.02 | 2019-2025 | Atricure Cryoice Cryoablation System (Cryo2), Synergy Ablation System, Isolator Surgical Ablation System |
| Abiomed | $3,120.57 | 2022-2025 | Impella |
| Abbott Laboratories | $3,047.82 | 2019-2024 | Epic, Portico, Navitor |
| W. L. Gore & Associates, INC. | $1,828.56 | 2019 | |
| Edwards Lifesciences Corporation | $1,826.45 | 2019-2025 | Sapien 3 Ultra Resilia, Mitris Resilia Mitral Valve |
| Medtronic Vascular, INC. | $1,782.84 | 2019 | |
| Intuitive Surgical, INC. | $1,177.63 | 2025 | |
| Cook Medical LLC | $726.79 | 2019-2025 | Cook |
| Medtronic, INC. | $686.75 | 2021-2025 | Corevalve Evolut R, Ffrangio |
| Endologix LLC | $178.96 | 2020 | |
| Getinge USA Sales, LLC | $148.81 | 2024 | Vasoview Hemopro 2 |
| Cvrx, INC. | $139.34 | 2019 | |
| Lsi Solutions INC | $138.80 | 2019 | |
| Merck Sharp & Dohme LLC | $33.12 | 2025 | Keytruda |
| Kls-Martin L.P. | $27.76 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $18.73 | 2024 | Xarelto |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Manabu Takebe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.